banner
Iodoacetate agent, Lentinan-PEG-iodoacetate, Purity ≥95%

Cat. No.: X25-05-YM663

Iodoacetate agent, Lentinan-PEG-iodoacetate, Purity ≥95%

Synonym: Lentinan-PEG-iodoacetate; Iodoacetate-PEG-Lentinan

img
Product Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
Price
Datasheet
MSDS
Sub Cat. No. Molecular Weight Glycan Name Functional Group Inquiry
X25-05-YM663-1 PEG 350 Da Lentinan Iodoacetate Inquiry
X25-05-YM663-2 PEG 550 Da Lentinan Iodoacetate Inquiry
X25-05-YM663-3 PEG 750 Da Lentinan Iodoacetate Inquiry
X25-05-YM663-4 PEG 1 kDa Lentinan Iodoacetate Inquiry
X25-05-YM663-5 PEG 2 kDa Lentinan Iodoacetate Inquiry
X25-05-YM663-6 PEG 3 kDa Lentinan Iodoacetate Inquiry
X25-05-YM663-7 PEG 4 kDa Lentinan Iodoacetate Inquiry
X25-05-YM663-8 PEG 5 kDa Lentinan Iodoacetate Inquiry
X25-05-YM663-9 PEG 10 kDa Lentinan Iodoacetate Inquiry
X25-05-YM663-10 PEG 20 kDa Lentinan Iodoacetate Inquiry
Properties
Description
Lentinan-PEG-iodoacetate, referenced as iodoacetate-lentinan, engineers a halogenated conjugate via polyethylene glycol spacers linking iodoacetyl groups to lentinan's β-glucan framework. This thiol-reactive derivative preserves triple-helix conformation while enabling cysteine-specific bioconjugation for targeted thymic delivery.
Glycan Structure
Its glycan structure is a β-(1→3)-linked d-glucose backbone with β-(1→6)-glucosyl side branches.
Source
Chemical synthesis
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Solubility
This product is soluble in most organic solvents, such as DCM, DMF, DMSO, and THF, and exhibits excellent solubility in water.
Identity
Confirmed by NMR.
Applications
Lentinan-PEG-iodoacetate can be used for its potential to create retinoic acid-PEG complexes for nuclear receptor targeting in differentiation assays.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0